News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,419 Results
Type
Article (5015)
Company Profile (17)
Press Release (220387)
Section
Business (82200)
Career Advice (461)
Deals (15042)
Drug Delivery (8)
Drug Development (19061)
Employer Resources (30)
FDA (3676)
Job Trends (3901)
News (120103)
Policy (7502)
Tag
Academia (292)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14778)
ALS (20)
Alzheimer's disease (247)
Antibody-drug conjugate (ADC) (11)
Approvals (3695)
Artificial intelligence (43)
Autoimmune disease (3)
Automation (3)
Bankruptcy (97)
Best Places to Work (2862)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (10)
Brain cancer (7)
Breast cancer (48)
Cancer (456)
Cardiovascular disease (24)
Career advice (393)
Career pathing (3)
CAR-T (33)
Cell therapy (107)
Cervical cancer (2)
Clinical research (16040)
Collaboration (172)
Compensation (172)
Complete response letters (2)
COVID-19 (301)
CRISPR (8)
C-suite (110)
Cystic fibrosis (16)
Data (526)
Depression (7)
Diabetes (43)
Diagnostics (2042)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40917)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37839)
Executive appointments (315)
FDA (3941)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (185)
Gene editing (16)
Generative AI (2)
Gene therapy (53)
GLP-1 (109)
Government (412)
Guidances (21)
Healthcare (5035)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (317)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7825)
IRA (3)
Job creations (1121)
Job search strategy (360)
Kidney cancer (7)
Labor market (5)
Layoffs (100)
Leadership (5)
Legal (2332)
Liver cancer (17)
Lung cancer (54)
Lymphoma (32)
Management (10)
Manufacturing (50)
MASH (29)
Medical device (3862)
Medtech (3863)
Mergers & acquisitions (7426)
Metabolic disorders (125)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (345)
NextGen: Class of 2025 (1674)
Non-profit (727)
Now hiring (3)
Obesity (53)
Opinion (30)
Ovarian cancer (17)
Pain (14)
Pancreatic cancer (14)
Parkinson's disease (28)
Partnered (4)
Patents (21)
Patient recruitment (33)
Peanut (5)
People (24608)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4783)
Phase II (6964)
Phase III (5551)
Pipeline (577)
Policy (9)
Postmarket research (625)
Preclinical (1873)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (70)
Real estate (1874)
Recruiting (8)
Regulatory (5126)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (4)
Schizophrenia (21)
Series A (28)
Series B (23)
Sickle cell disease (7)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (4)
Startups (1009)
Stomach cancer (1)
Supply chain (10)
Tariffs (5)
Vaccines (37)
Venture capitalists (2)
Weight loss (22)
Women's health (1)
Date
Today (8)
Last 7 days (243)
Last 30 days (693)
Last 365 days (9860)
2025 (3235)
2024 (11028)
2023 (13195)
2022 (18660)
2021 (19678)
2020 (18238)
2019 (13205)
2018 (10206)
2017 (10001)
2016 (9156)
2015 (12118)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11462)
Australia (1611)
California (1994)
Canada (718)
China (73)
Colorado (84)
Connecticut (97)
Delaware (30)
Europe (24547)
Florida (287)
Georgia (34)
Idaho (23)
Illinois (117)
India (7)
Indiana (64)
Iowa (2)
Japan (75)
Kansas (24)
Kentucky (11)
Louisiana (5)
Maine (40)
Maryland (226)
Massachusetts (1597)
Michigan (86)
Minnesota (141)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (16)
New Jersey (577)
New Mexico (5)
New York (480)
North Carolina (332)
North Dakota (3)
Northern California (950)
Ohio (60)
Oklahoma (5)
Oregon (4)
Pennsylvania (353)
Puerto Rico (1)
Rhode Island (13)
South America (276)
South Carolina (6)
Southern California (719)
Tennessee (40)
Texas (230)
United States (7213)
Utah (61)
Virginia (47)
Washington D.C. (9)
Washington State (177)
West Virginia (2)
Wisconsin (25)
225,419 Results for "immunobiochem corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
ImmunoBiochem Announces Multi-Target License and Option Agreement with ImmunoGen to Develop Next-Generation Antibody-Drug Conjugates
ImmunoBiochem Corporation announced a multi-target license and option agreement with ImmunoGen, Inc., a leader in the expanding field of antibody-drug conjugates, to advance novel, first-in-class ADCs.
July 24, 2023
·
4 min read
Genetown
ImmunoGen Announces Multi-Target License and Option Agreement with ImmunoBiochem to Develop Next-Generation Antibody-Drug Conjugates
ImmunoGen, Inc. announced a multi-target license and option agreement to research novel, first-in-class ADCs with ImmunoBiochem Corporation, a privately-held biopharmaceutical company focused on the discovery of unique tumor targets and development of novel biological therapeutics.
July 24, 2023
·
5 min read
Business
ImmunoGen Inks Cancer ADC Partnership with ImmunoBiochem
The license and option deal, for an undisclosed amount, seeks to develop potentially first-in-class antibody-drug conjugate candidates against different oncology targets.
July 25, 2023
·
2 min read
·
Tristan Manalac
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
Press Releases
Quantum BioPharma Corporate Update
April 21, 2025
·
4 min read
Press Releases
Healthcare Integrated Technologies Inc. Announces Corporate Name Change to SafeSpace Global Corporation and Ticker Symbol Update
April 24, 2025
·
2 min read
Press Releases
Orion Corporation: Managers’ transactions – Maziar Mike Doustdar
May 2, 2025
·
1 min read
Press Releases
CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller
April 17, 2025
·
7 min read
Press Releases
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
March 26, 2025
·
17 min read
Press Releases
Lobe Sciences Provides Corporate Update
April 7, 2025
·
8 min read
1 of 22,542
Next
